These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 1460865

  • 61. Morphologic and immunohistochemical observations in granulomatous glomerulonephritis.
    Bhathena DB, Migdal SD, Julian BA, McMorrow RG, Baehler RW.
    Am J Pathol; 1987 Mar; 126(3):581-91. PubMed ID: 3548411
    [Abstract] [Full Text] [Related]

  • 62. Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis.
    Cook HT, Khan SB, Allen A, Bhangal G, Smith J, Lobb RR, Pusey CD.
    Am J Pathol; 2002 Oct; 161(4):1265-72. PubMed ID: 12368200
    [Abstract] [Full Text] [Related]

  • 63. [The effect of transfused marrow monocytes on Masugi nephritis in rabbits with radiation injury].
    Ding XY, Hu YF.
    Zhonghua Bing Li Xue Za Zhi; 1992 Aug; 21(4):209-11. PubMed ID: 1473204
    [Abstract] [Full Text] [Related]

  • 64. De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis.
    Lan HY, Mu W, Yang N, Meinhardt A, Nikolic-Paterson DJ, Ng YY, Bacher M, Atkins RC, Bucala R.
    Am J Pathol; 1996 Oct; 149(4):1119-27. PubMed ID: 8863661
    [Abstract] [Full Text] [Related]

  • 65. The glomerular crescent: triggers, evolution, resolution, and implications for therapy.
    Anguiano L, Kain R, Anders HJ.
    Curr Opin Nephrol Hypertens; 2020 May; 29(3):302-309. PubMed ID: 32132388
    [Abstract] [Full Text] [Related]

  • 66. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis.
    Kitching AR, Tipping PG, Timoshanko JR, Holdsworth SR.
    Kidney Int; 2000 Feb; 57(2):518-25. PubMed ID: 10652028
    [Abstract] [Full Text] [Related]

  • 67. Neutrophils associate with Bowman's capsule rupture specifically in PR3-ANCA glomerulonephritis.
    Hakroush S, Tampe B.
    J Nephrol; 2022 May; 35(4):1177-1183. PubMed ID: 34851509
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Pharmacological inhibition of protease-activated receptor-2 reduces crescent formation in rat nephrotoxic serum nephritis.
    Han Y, Tian L, Ma F, Tesch G, Vesey DA, Gobe GC, Lohman RJ, Morais C, Suen JY, Fairlie DP, Nikolic-Paterson DJ.
    Clin Exp Pharmacol Physiol; 2019 May; 46(5):456-464. PubMed ID: 30811624
    [Abstract] [Full Text] [Related]

  • 70. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation.
    Ng YY, Fan JM, Mu W, Nikolic-Paterson DJ, Yang WC, Huang TP, Atkins RC, Lan HY.
    Nephrol Dial Transplant; 1999 Dec; 14(12):2860-72. PubMed ID: 10570089
    [Abstract] [Full Text] [Related]

  • 71. Crescentic glomerulonephritis: a clinicopathologic analysis of 17 cases with emphasis on glomerular and interstitial neutrophil infiltration.
    Suh KS, Kim BK, Kim KH.
    J Korean Med Sci; 1999 Jun; 14(3):293-8. PubMed ID: 10402172
    [Abstract] [Full Text] [Related]

  • 72. The mesangial cell in glomerulonephritis. I. Mechanisms of hypercellularity in experimental immune complex glomerulonephritis.
    Bradfield JW, Cattell V.
    Lab Invest; 1977 May; 36(5):481-6. PubMed ID: 140954
    [Abstract] [Full Text] [Related]

  • 73. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
    Khan SB, Cook HT, Bhangal G, Smith J, Tam FW, Pusey CD.
    Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
    [Abstract] [Full Text] [Related]

  • 74. ICAM-1 directs migration and localization of interstitial leukocytes in experimental glomerulonephritis.
    Hill PA, Lan HY, Nikolic-Paterson DJ, Atkins RC.
    Kidney Int; 1994 Jan; 45(1):32-42. PubMed ID: 8127019
    [Abstract] [Full Text] [Related]

  • 75. [Monoclonal antibody analysis of glomerular, tubulo-interstitial infiltrating immune cells in various glomerulonephritis].
    Oda T, Yoshizawa N, Oshima S, Takeuchi A, Kubota T, Kondo S, Oshikawa Y, Akashi Y, Suzuki Y, Niwa H.
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):631-41. PubMed ID: 2214313
    [Abstract] [Full Text] [Related]

  • 76. CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis.
    Wu J, Hicks J, Borillo J, Glass WF, Lou YH.
    J Clin Invest; 2002 Feb; 109(4):517-24. PubMed ID: 11854324
    [Abstract] [Full Text] [Related]

  • 77. Crescents in diabetic glomerulopathy. Incidence and clinical significance.
    Elfenbein IB, Reyes JW.
    Lab Invest; 1975 Dec; 33(6):687-95. PubMed ID: 1202285
    [Abstract] [Full Text] [Related]

  • 78. Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats.
    Takeda S, Takahashi M, Sado Y, Takeuchi K, Hakamata Y, Shimizu H, Kaneko T, Yamamoto H, Ito C, Ookawara S, Asano Y, Kusano E, Kobayashi E.
    Nephrol Dial Transplant; 2004 Sep; 19(9):2228-36. PubMed ID: 15238626
    [Abstract] [Full Text] [Related]

  • 79. c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat.
    Han Y, Ma FY, Tesch GH, Manthey CL, Nikolic-Paterson DJ.
    Lab Invest; 2011 Jul; 91(7):978-91. PubMed ID: 21519331
    [Abstract] [Full Text] [Related]

  • 80. Patterns of glomerulonephritis with crescents: Experience at a tertiary medical center in Saudi Arabia.
    Al-Hussain T, Asiri S, Amer S, Al Mana H, Akhtar M.
    Saudi J Kidney Dis Transpl; 2017 Jul; 28(3):532-537. PubMed ID: 28540889
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.